Enzymatic Membrane Reactor for Resolution of Ketoprofen in Ionic Liquids and Supercritical Carbon Dioxide. In: Malhotra SV, editor. Ionic Liquid Applications: Pharmaceuticals, Therapeutics, and Biotechnology. Washington: American Chemical Society; 2010. pp. 25-34. [DOI: 10.1021/bk-2010-1038.ch003]

Relevance and bio-catalytic strategies for the kinetic resolution of ketoprofen towards dexketoprofen

This review presents the most relevant investigations concerning the biocatalytic kinetic resolution of racemic ketoprofen to dexketoprofen for the last 22 years. The advantages related to the administration of the dex-enantiomer in terms of human health, the so called "chiral switch" in the pharmaceutical industry and the sustainability of biotransformations have been the driving forces to develop innovative technology to obtain dexketoprofen. In particular, the kinetic resolution of racemic ketoprofen through enantiomeric esterification and hydrolysis using lipases as biocatalysts are thoroughly revised and commented upon. In this context, the biocatalysts, acyl-acceptors (alcohols), reaction conditions, conversion, enantiomeric excess, and enantiomeric ratio among others are discussed. Moreover, the investigations concerning scaling up processes in order to obtain an optically pure enantiomer of the profen are presented. Finally, some guidelines about perspectives of the technology and research opportunities are given.